Virologic failure and salvage therapy
- PMID: 11365357
Virologic failure and salvage therapy
Abstract
AIDS: Researchers indicate that virologic failure during protease inhibitor (PI) therapy does not equate to clinical failure, and several studies reveal hopeful data on salvage therapy. One study suggests that salvage therapy after nelfinavir failure may be feasible with ritonavir/saquinavir. Other studies are showing that limited efficacy of ritonavir/saquinavir after failure of indinavir may be associated with a delay in switching to salvage therapy. Finally, some studies have shown that 9 of 12 patients who have failed multiple therapies, but were naive to nelfinavir and nevirapine and treated with d4T, ddI, 3TC, nevirapine, nelfinavir, and saquinavir, achieved undetectable viral load at 12 weeks.
Similar articles
-
Failure of double protease inhibitor therapy as a salvage therapy for HIV-infected patients resistant to conventional triple therapy.Eur J Med Res. 1999 Jul 28;4(7):271-4. Eur J Med Res. 1999. PMID: 10425264 Clinical Trial.
-
Rescue me.Res Initiat Treat Action. 1998 Aug;4(5):10. Res Initiat Treat Action. 1998. PMID: 11365705
-
Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.Prescrire Int. 2004 Aug;13(72):144-50. Prescrire Int. 2004. PMID: 15532140
-
A review of dual protease inhibitor therapy.Hopkins HIV Rep. 1998 May;10(3):1, 4-5. Hopkins HIV Rep. 1998. PMID: 11365490 Review.
-
[Salvage therapy in HIV disease].Nihon Rinsho. 2002 Apr;60(4):745-9. Nihon Rinsho. 2002. PMID: 11968782 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous